Trials / Completed
CompletedNCT02323672
Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions
Salivary and Serum Levels of Chemerin and MMP-9 in Oral Precancer and Oral Squamous Cell Carcinoma.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 40 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
45 individuals were subdivided into 3 groups, 15 patients with oral premalignant lesions, 15 patients with oral malignant lesions and 15 control individuals. Levels of chemerin and MMP-9 were evaluated in serum and saliva of these subjects utilizing the ELISA technique.
Detailed description
45 individuals were subdivided into 3 groups, 15 patients suffering from oral premalignant lesions, 15 patients suffering from oral malignant lesions and 15 individuals having age, gender and periodontal status matched with both patients groups acting as a control group. Serum and whole unstimulated saliva samples were collected from all the included groups in order to determine chemerin and MMP-9 in serum and saliva utilizing the ELISA technique.
Conditions
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-09-01
- Completion
- 2014-10-01
- First posted
- 2014-12-23
- Last updated
- 2017-02-10
Source: ClinicalTrials.gov record NCT02323672. Inclusion in this directory is not an endorsement.